Vor Biopharma (VOR)

• Market cap: $1.38B
• 1 day: 1.17%
• 5 days: -0.85%
• 1 month: 33.41%
• 3 months: 64.76%
• 6 months: 76.36%
• Year to date: 100%
• 1 year: -42.94%
• 5 years: -91.7%
• 10 years: -96.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Employees: 76